VOYAGER THERAPEUTICS INC's ticker is VYGR and the CUSIP is 92915B106. A total of 106 filers reported holding VOYAGER THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.51 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,848,824 | -31.1% | 367,590 | +1.9% | 0.26% | -31.3% |
Q2 2023 | $4,131,733 | +716.4% | 360,850 | +334.9% | 0.38% | +783.7% |
Q4 2022 | $506,099 | -2.9% | 82,967 | -5.7% | 0.04% | -8.5% |
Q3 2022 | $521,000 | +349.1% | 87,967 | +347.3% | 0.05% | +422.2% |
Q2 2022 | $116,000 | -81.8% | 19,667 | -46.8% | 0.01% | -83.9% |
Q3 2019 | $637,000 | – | 37,000 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRV GP III, LLC | 7,891,176 | $154,194,000 | 51.35% |
Trustees of Princeton University | 203,638 | $3,979,000 | 4.13% |
Casdin Capital, LLC | 1,135,000 | $22,178,000 | 3.10% |
GREAT POINT PARTNERS LLC | 730,010 | $14,264,000 | 1.98% |
BB BIOTECH AG | 2,532,641 | $49,488,000 | 1.43% |
Aevitas Wealth Management, Inc. | 73,323 | $1,433,000 | 1.40% |
Patriot Financial Group Insurance Agency, LLC | 64,256 | $1,256,000 | 1.34% |
Virtus ETF Advisers LLC | 37,502 | $733,000 | 0.65% |
Eventide Asset Management | 703,425 | $13,745,000 | 0.57% |
THOMPSON DAVIS & CO., INC. | 11,951 | $234,000 | 0.56% |